Syndax Pharmaceuticals Inc (SNDX) — Capital Reinvestment Ratio
Syndax Pharmaceuticals Inc (SNDX) has a Capital Reinvestment Ratio of 0.00x as of December 2021, meaning it reinvests 0% of its operating cash flow ($100.71 Million) in capital expenditures ($129.00K). See how leveraged is Syndax Pharmaceuticals Inc's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Syndax Pharmaceuticals Inc Capital Reinvestment Ratio (2021–2021)
This chart tracks Syndax Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Check SNDX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Syndax Pharmaceuticals Inc (2021–2021)
Year-by-year Capital Reinvestment Ratio for Syndax Pharmaceuticals Inc from 2021 to 2021. For live market cap and broader valuation context, see Syndax Pharmaceuticals Inc (SNDX) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.00x | $29.13 Million | $129.00K | — |